XML 47 R32.htm IDEA: XBRL DOCUMENT v3.24.0.1
FAIR VALUE (Tables)
 12 Months Ended
Dec. 31, 2023
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the fair value hierarchy for our assets and liabilities measured at fair value on a recurring basis (in thousands):
Fair Value
Level in FairDecember 31,
Value Hierarchy20232022
Assets:
Other non-current assets:
Equity securities (1)
1$310 $723 
Liabilities:
Other long-term liabilities:
Contingent consideration associated with acquisitions3$8,896 $13,400 
(1) Represents our investments in autonomous technology companies. For additional information regarding the valuation of these equity securities, see Note 7 – Investments.
Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
The following table presents changes in the fair value of our contingent earnout liabilities for the years ended December 31, 2023 and 2022 (in thousands):
Balance as of December 31, 2021$2,500 
Contingent consideration associated with the acquisition of Baylor 8,400 
Contingent consideration associated with the acquisition of ReedTMS 5,000 
Change in fair value (1)
(2,500)
Balance as of December 31, 202213,400 
Measurement period adjustment associated with the acquisition of ReedTMS (2)
(800)
Payment for contingent consideration (3)
(1,500)
Change in fair value (4)
(2,204)
Balance as of December 31, 2023$8,896 
(1) The contingent earnout period related to the NEHDS acquisition ended on December 31, 2022 and did not result in any additional cash payments, as the financial performance goals were not achieved.
(2) The measurement period adjustment was recorded in goodwill on the consolidated balance sheet.
(3) The contingent earnout period related to the ReedTMS acquisition ended on December 31, 2023 and resulted in an additional cash payment, as certain financial performance goals were achieved.
(4) Includes a net favorable change of $2.7 million to the contingent earnout liability related to the ReedTMS acquisition for the year ended December 31, 2023.